The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...
The Centers for Disease Control and Prevention (CDC) has come out with a strong recommendation for the use of Gilead Sciences’ twice-yearly HIV pre-exposure prophylaxis (PrEP) med Yeztugo, ...
– Approval Based on Phase 3 PURPOSE 1 and PURPOSE 2 Data that Showed ≥99.9% of Participants Remained HIV Negative on Twice-Yearly Injectable Yeztugo – – Yeztugo, Nearly 20 Years in the Making, ...
9don MSN
Georgia bill would allow pharmacists to prescribe PrEP in effort to expand HIV prevention access
A bill moving through the Georgia General Assembly could allow trained pharmacists to prescribe PrEP, a daily medication that can prevent HIV.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results